JAK2 inhibitor blocks the inflammation and growth of esophageal squamous cell carcinoma in vitro through the JAK/STAT3 pathway
Juemin Fang(Tongji University), Qing Xu(Shanghai Medical College of Fudan University)
Cited by 35
Related Papers
The emerging treatment landscape of targeted therapy in non-small-cell lung cancer
|Signal Transduction and Targeted Therapy|2019|699
STAT3 Contributes To Oncolytic Newcastle Disease Virus-Induced Immunogenic Cell Death in Melanoma Cells
|Frontiers in Oncology|2019|57
Inhibition of autophagy in hepatocarcinoma cells promotes chemotherapeutic agent-induced apoptosis during nutrient deprivation
|Oncology Reports|2017|12
Parallel CD19/CD20 CAR-Activated T-Cells Are More Effective for Refractory B-Cell Lymphoma In Vitro and In Vivo
|Evidence-based Complementary and Alternative Medicine|2022|3